The Enterprise Value as of September 2024 (TTM) for Verrica Pharmaceuticals Inc. (VRCA) is 95.02M

According to Verrica Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 95.02M. This represents a change of -65.76% compared to the average of 277.56M of the last 4 quarters.

Verrica Pharmaceuticals Inc. (VRCA) Historical Enterprise Value (quarterly & annually)

How has VRCA Enterprise Value performed in the past?

The mean historical Enterprise Value of Verrica Pharmaceuticals Inc. over the last ten years is 257.75M. The current 95.02M Enterprise Value has changed 3.59% with respect to the historical average. Over the past ten years (40 quarters), VRCA's Enterprise Value was at its highest in in the March 2018 quarter at 409.08M. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Verrica Pharmaceuticals Inc. (VRCA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Verrica Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Verrica Pharmaceuticals Inc. (VRCA) Average Enterprise Value

How has VRCA Enterprise Value performed in the past?

The current Enterprise Value of Verrica Pharmaceuticals Inc. (VRCA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Verrica Pharmaceuticals Inc. (VRCA) Enterprise Value vs. Peers

How is VRCA’s Enterprise Value compared to its peers?

Verrica Pharmaceuticals Inc.’s Enterprise Value is greater than LianBio (-66141903.00), less than Inventiva S.A. (114.51M), less than Edgewise Therapeutics, Inc. (1.55B), less than Vigil Neuroscience, Inc. (119.82M), greater than Connect Biopharma Holdings Limited (-39789702.00), less than Acumen Pharmaceuticals, Inc. (113.16M), less than Eton Pharmaceuticals, Inc. (128.77M), less than Nuvation Bio Inc. (1.01B), greater than Eledon Pharmaceuticals, Inc. (79.70M), less than Verona Pharma plc (2.25B), greater than Galera Therapeutics, Inc. (-5796499.00), less than Arcutis Biotherapeutics, Inc. (1.32B), greater than Protalix BioTherapeutics, Inc. (82.19M), less than Chinook Therapeutics, Inc. (2.61B), less than DICE Therapeutics, Inc. (2.21B), less than Pliant Therapeutics, Inc. (700.64M), less than Crinetics Pharmaceuticals, Inc. (4.08B), less than Ascendis Pharma A/S (7.64B), less than Fennec Pharmaceuticals Inc. (129.28M), less than Larimar Therapeutics, Inc. (400.15M), greater than Homology Medicines, Inc. (-103303255.00),

Build a custom stock screener for Verrica Pharmaceuticals Inc. (VRCA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verrica Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verrica Pharmaceuticals Inc. (VRCA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verrica Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.